bevictorΰµÂ¹ÙÍø - ΤµÂ¹Ù·½ÍøÕ¾

6ÔÂ1ÈÕ£¬£¬£¬£¬£¬£¬£¬bevictorΰµÂ¹ÙÍø - ΤµÂ¹Ù·½Íøվ֮ȫ×ÊÁ¥Êô¹«Ë¾ invoX Pharma Limited£¬£¬£¬£¬£¬£¬£¬Ò»¼Ò×ܲ¿ÉèÓÚÓ¢¹úÇÒÓµÓÐÒ»Ö±Éú³¤µÄÁ¢Òì²úÆ·¹ÜÀ‰µÄ¹«Ë¾£¬£¬£¬£¬£¬£¬£¬Ðû²¼ÆäÒÑÍê³É¶ÔÏÂÒ»´ú mRNA ÒßÃ繫˾ pHion Therapeutics£¨pHion£©µÄµÚ¶þ±ÊͶ×Ê¡£¡£¡£¡£¡£¡£¡£¡£¸ÃÉúÒâ¹á³¹ÁË invoX ÏòÖÜÈ«×ÛºÏÐÍbevictorΰµÂ¹ÙÍø - ΤµÂ¹Ù·½ÍøÕ¾¹«Ë¾Éú³¤µÄÕ½ÂÔ£¬£¬£¬£¬£¬£¬£¬²¢Åú×¢ÎúÆä¶ÔÌṩÁ¢Òì¾ÈÉúÁÆ·¨µÄ¿ÌÒâ¡£¡£¡£¡£¡£¡£¡£¡£

pHion ÖÂÁ¦ÓÚ¿ª·¢Ò»ÏµÁÐרעÓÚÖ×ÁöÁìÓòºÍѬȾÐÔ¼²²¡ÁìÓòµÄÖÎÁÆÐÔ¼°Ô¤·ÀÐÔÒßÃç¡£¡£¡£¡£¡£¡£¡£¡£¸Ã¹«Ë¾×¨ÓÐµÄ RALA ƽ̨¿ÉÒÔÒÔÒþ²ØµÄ·½·¨µÝËÍ mRNA ºÍ saRNA µÈÒõÀë×Ó·Ö×Ó£¬£¬£¬£¬£¬£¬£¬Ìӱܼì²â£¬£¬£¬£¬£¬£¬£¬´Ó¶ø±¬·¢ÓÐÓõĿ¹Ô­ÌØÒìÐÔ CD8+T ϸ°û·´Ó¦¡£¡£¡£¡£¡£¡£¡£¡£»£»£»£»£»£»ùÓÚ RALA ëĵÄÒ©ÎïµÝËÍϵͳÓÐÒ»×éÓÉ30¸ö°±»ùËá×é³ÉµÄÐòÁУ¬£¬£¬£¬£¬£¬£¬¿ÉÒÔ½«ÒõÀë×Ó·Ö×Ó£¬£¬£¬£¬£¬£¬£¬ÎÞÂÛ¾Þϸ£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬£¬Å¨Ëõ³ÉÄÉÃ׿ÅÁ££¬£¬£¬£¬£¬£¬£¬ÕâЩÄÉÃ׿ÅÁ£ÔÚ½øÈëϸ°ûʱºÜÊǸßЧ£¬£¬£¬£¬£¬£¬£¬ÓÅÓÚÆäËûÒÑÓÐÊÖÒÕ¡£¡£¡£¡£¡£¡£¡£¡£Óë¹Å°åµÄ mRNA ÒßÃçµÝËÍƽ̨Ïà±È£¬£¬£¬£¬£¬£¬£¬RALA ƽ̨¾ßÓÐÒ×ÓÚÀ©Õ¹ºÍµÝË͵ÄÓÅÊÆ£¬£¬£¬£¬£¬£¬£¬ÆäÖаüÀ¨ÊÒÎÂϵÄÎȹ̡£¡£¡£¡£¡£¡£¡£¡£

×Ô invoX ÓÚ2021Äê6Ô¾ÙÐгõʼͶ×ÊÒÔÀ´£¬£¬£¬£¬£¬£¬£¬pHion ÔÚÆäÊ×ϯִÐйټæÊ×´´ÈË Helen McCarthy ½ÌÊÚµÄÏòµ¼Ï£¬£¬£¬£¬£¬£¬£¬ÒÑÈ¡µÃÁËÖØ´óÏ£Íû£¬£¬£¬£¬£¬£¬£¬°üÀ¨ËùÓÐÁÙ´²Ç°ÏîÄ¿µÄÏ£Íû£¬£¬£¬£¬£¬£¬£¬ÒÔ¼°ÔÚ±±°®¶ûÀ¼±´¶û·¨Ë¹Ìؽ¨ÉèÁËÒ»¸öʵÑéÊÒ£¬£¬£¬£¬£¬£¬£¬ÓÃÓÚÉú²úpHionµÄ mRNA ÒßÃç¡£¡£¡£¡£¡£¡£¡£¡£´Ë´ÎÌØÊâͶ×ʽ«Ö§³Ö pHion רÓÐµÄ RALA ƽ̨µÄÉú³¤£¬£¬£¬£¬£¬£¬£¬²¢×ÅÖØÓÚÔÚ2024ÄêÉÏ°ëÄ꽫pHionµÄÁìÏÈÏîÄ¿ PTX_V1 Íƽø¹âÁÙ´²ÊÔÑé½×¶Î¡£¡£¡£¡£¡£¡£¡£¡£PTX_V1 ÊÇÒ»ÖÖͬÀàÊ×´´ (first-in-class) µÄÖÎÁÆÐÔÒßÃ磬£¬£¬£¬£¬£¬£¬ÓÃÓÚÖÎÁÆÈËÈéÍ·Áö²¡¶¾ (HPV) Ïà¹Ø°©Ö¢¡£¡£¡£¡£¡£¡£¡£¡£Ô¼Äª90%µÄ¹¬¾±°©ºÍ¸ß´ï70%µÄ¿ÚÑÊ°©ÓÉHPVѬȾµ¼Ö£¬£¬£¬£¬£¬£¬£¬ÇÒ´ó×ÚÁÙ´²ÐèÇóÉÐδ±»Öª×ã¡£¡£¡£¡£¡£¡£¡£¡£pHionµÄ¹ÜÏß»¹°üÀ¨ÓÃÓÚÖÎÁÆÂѳ²°© (PTX_V5) ºÍÇ°ÏßÏÙ°© (PTX_V3) µÄ²î±ð»¯µÄÖÎÁÆÐÔÒßÃç¡£¡£¡£¡£¡£¡£¡£¡£

ÕâÏîͶ×ÊÒÑ»ñµÃËùÓÐÐëÒªµÄî¿ÏµÅú×¼£¬£¬£¬£¬£¬£¬£¬°üÀ¨ÈÏÕæÖ´ÐÐÓ¢¹ú¡¶¹ú¼ÒÇå¾²ºÍͶ×Ê·¨°¸¡·(National Security and Investment Act) µÄî¿Ïµ»ú¹¹µÄÅú×¼£¬£¬£¬£¬£¬£¬£¬ÌåÏÖÁËinvoXÒ»Á¬Óëî¿Ïµ»ú¹¹½¨ÉèÐÅÍйØϵ²¢¼á³ÖÇ×½üÏàÖú¡£¡£¡£¡£¡£¡£¡£¡£

pHion Ê×ϯִÐйټæÊ×´´ÈË Helen McCarthy ½ÌÊÚÌåÏÖ£º“ÔÚ pHion   Therapeutics£¬£¬£¬£¬£¬£¬£¬bevictorΰµÂ¹ÙÍø - ΤµÂ¹Ù·½ÍøվʹÃüÊÇͨ¹ýÒþ²ØʽµÄ mRNA µÝËÍÀ´¿ª´´ÏÂÒ»´úͬÀàÊ×´´ (first-in-class) µÄѬȾÐÔ¼²²¡¼°Ö×ÁöÒßÃç¡£¡£¡£¡£¡£¡£¡£¡£ÔÚ invoX µÄÌØÊâÖ§³ÖÏ£¬£¬£¬£¬£¬£¬£¬ÎÒÃǽ«¼ÓËÙ¿ª·¢bevictorΰµÂ¹ÙÍø - ΤµÂ¹Ù·½ÍøÕ¾ÁìÏȺòÑ¡Ò©Î£¬£¬£¬£¬£¬£¬PTX_V1£¬£¬£¬£¬£¬£¬£¬Ê¹ÆäÔÚ2024Äê½øÈëÁÙ´²½×¶Î£¬£¬£¬£¬£¬£¬£¬²¢½øÒ»²½Éú³¤ÎÒÃǼ¤¸ÐÈËÐĵÄÁÙ´²Ç°ÖÎÁÆÐÔºÍÔ¤·ÀÐÔmRNAÒßÃç¹ÜÏß¡£¡£¡£¡£¡£¡£¡£¡£mRNA ÒßÃçÓпÉÄÜÔÚÈ«Çò¹æÄ£ÄÚÕæÕýµÄ¸Ä±äÒ½ÁƱ£½¡¸ÉÔ¤²½·¥£¬£¬£¬£¬£¬£¬£¬¶ø pHion ½«ÔÚ RALA ƽ̨µÝËÍÊÖÒÕµÄÖ§³ÖÏÂÕ¾ÔÚÕâһת±äµÄ×îÇ°ÑØ¡£¡£¡£¡£¡£¡£¡£¡£”

invoX Ê×ϯִÐй٠Ben Toogood ÌåÏÖ£º“ÎÒÃǺÜÐË·ÜÍê³É¶ÔpHionµÄÌØÊâͶ×Ê¡£¡£¡£¡£¡£¡£¡£¡£invoX µÄ×ÊÔ´¡¢È«ÇòÓ°ÏìÁ¦ºÍÁ¢ÒìÑз¢Æ½Ì¨¿ÉÒÔ×ÊÖú pHion ʩչDZÁ¦£¬£¬£¬£¬£¬£¬£¬ÎªÌìϸ÷µØ»¼Óа©Ö¢ºÍѬȾÐÔ¼²²¡µÄ»¼ÕßÌṩÖÎÁÆ¡£¡£¡£¡£¡£¡£¡£¡£ÎÒÃÇÆÚ´ý¿´µ½ PTX_V1 ½øÈëÁÙ´²½×¶Î£¬£¬£¬£¬£¬£¬£¬²¢Íƶ¯¸ÃÏîÄ¿½øÈëÏÂÒ»½×¶ÎµÄ¿ª·¢¡£¡£¡£¡£¡£¡£¡£¡£”

¹ØÓÚpHion Therapeutics